Summary: Nyxoah SA presented additional data from its DREAM US study on the Genio neurostimulation system for treating obstructive sleep apnea (OSA) at the 2024 International Surgical Sleep Society (ISSS) Educational Update, which showed that Genio’s bilateral stimulation … [Read more...]
Genio Neurostimulator Maker Gears Up for Anticipated US Market Entry
Summary: Nyxoah SA, the maker of the CE-marked Genio neurostimulator system for obstructive sleep apnea, reported its financial and operational results for the second quarter and first half of 2024. The company has completed its FDA regulatory submission for Genio and expects a … [Read more...]
Neurostimulator Developer StimAire Appoints Industry Vet as COO
Summary: StimAire, a company developing an injectable neurostimulator to treat obstructive sleep apnea (OSA), has appointed Arthur Rascon as its new chief operating officer (COO). Rascon brings over two decades of experience in the medical device industry, having previously held … [Read more...]
Neurostimulator Support Groups: Finding Strength, Solace Online
By Alyx Arnett Mike Dingledine from Ohio, Lisa Ganey from Arizona, Christina “Lilly” Drake from Maryland, and Harold Roettger from Minnesota—these are just a few of the many individuals who have found solace and strength in online support groups for neurostimulators for sleep … [Read more...]
Inspire Recalls Component of Neurostimulator Therapy for OSA
Summary: Inspire Medical Systems has issued a recall for its Inspire IV implantable pulse generator used in treating obstructive sleep apnea due to a manufacturing defect. This defect may cause system malfunctions, including electrical leakage, potentially leading to serious … [Read more...]
Nyxoah Prepares Final FDA Module for Genio OSA Neurostimulator
Summary: Nyxoah described its Q1 2024 economic and operating outcomes, highlighting sizeable progress with its Genio program, a leadless and battery-cost-free hypoglossal neurostimulation therapy for obstructive snooze apnea (OSA). The Aspiration US pivotal study reached co-key … [Read more...]
Neurostimulator Helps Young Man with Down Syndrome and OSA
By Alyx Arnett For Amy Lopez, watching her son Nick Lopez, 20, who has Down syndrome, deal with obstructive sleep apnea (OSA) has been challenging. Diagnosed at a young age, Nick’s journey with OSA began early due to his Down syndrome-related anatomical challenges, including a … [Read more...]
LivaNova Concludes Enrollment in OSA Neurostimulator Trial
Summary: LivaNova announces completion of enrollment in the OSPREY trial for its aura6000 System, an implantable neurostimulator designed to address moderate to severe obstructive sleep apnea. The system, already CE marked, aims to maintain upper airway muscle tone, reducing or … [Read more...]
AHN Implants Central Sleep Apnea Patient with Neurostimulator
Summary: Allegheny Overall health Community has implanted the remedē system, a pacemaker-like program for treating central sleep apnea. The unit, which stimulates the diaphragm with electrical currents to restore standard respiration, presents an substitute to CPAP systems. … [Read more...]
Nexalin Ramps Up Manufacturing of Insomnia Neurostimulator
Summary: Nexalin Engineering Inc has properly examined its Gen-3 HALO Clarity neurostimulator, passing essential safety and design and style verifications, and the company is now boosting output to 500 units in anticipation of US clinical trials aimed at validating the device’s … [Read more...]